AlphaMark Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $88K | Hold |
3,735
| – | – | 0.04% | 189 |
|
|
2024
Q3 | $96K | Hold |
3,735
| – | – | 0.03% | 283 |
|
|
2024
Q2 | $88K | Sell |
3,735
-1,250
| -25% | -$29.5K | 0.03% | 294 |
|
|
2024
Q1 | $143K | Sell |
4,985
-125
| -2% | -$3.59K | 0.05% | 242 |
|
|
2023
Q4 | $168K | Buy |
5,110
+215
| +4% | +$7.07K | 0.06% | 234 |
|
|
2023
Q3 | $136K | Buy |
4,895
+100
| +2% | +$2.78K | 0.06% | 233 |
|
|
2023
Q2 | $163K | Buy |
4,795
+225
| +5% | +$7.65K | 0.08% | 121 |
|
|
2023
Q1 | $137K | Buy |
4,570
+505
| +12% | +$15.1K | 0.06% | 136 |
|
|
2022
Q4 | $115K | Sell |
4,065
-530
| -12% | -$15K | 0.06% | 139 |
|
|
2022
Q3 | $151K | Sell |
4,595
-55
| -1% | -$1.81K | 0.07% | 115 |
|
|
2022
Q2 | $146K | Sell |
4,650
-175
| -4% | -$5.5K | 0.07% | 120 |
|
|
2022
Q1 | $222K | Buy |
4,825
+415
| +9% | +$19.1K | 0.08% | 116 |
|
|
2021
Q4 | $270K | Sell |
4,410
-425
| -9% | -$26K | 0.09% | 115 |
|
|
2021
Q3 | $361K | Buy |
4,835
+140
| +3% | +$10.5K | 0.13% | 96 |
|
|
2021
Q2 | $434K | Sell |
4,695
-205
| -4% | -$19K | 0.16% | 85 |
|
|
2021
Q1 | $435K | Buy |
+4,900
| New | +$435K | 0.17% | 82 |
|